ORASURE TECHNOLOGIES INC (OSUR)

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.

Address

220 E FIRST ST

BETHLEHEM, PA 18015

Founded

2000

Number of Employees

638

Website

http://www.orasure.com

Buyback

Buyback Data	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
$ Amount Purchased ($ in 000s)	-	$6,090	$2,784	$1,239	$3,588	$3,713	$2,089	$2,113	$2,251	$1,953	$3,446	$2,927
Average Price	-	$6.70	$6.31	$10.17	$18.79	$12.85	$8.39	$13.89	$6.85	$4.58	$5.58	$7.86
# Shares Purchased	-	909,327	441,040	121,887	190,920	289,036	249,016	152,102	328,501	426,087	617,462	372,538

Buyback Performance	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
Total Return to Date	-	-40.3%	-36.6%	-60.7%	-78.7%	-68.9%	-52.3%	-71.2%	-41.6%	-12.7%	-28.3%	-49.1%
S&P 500 Return to Date	-	173.0%	168.6%	129.7%	104.9%	93.1%	74.8%	31.7%	37.3%	31.3%	7.4%	85.2%
Excess Total Return	-	-213.2%	-205.2%	-190.4%	-183.6%	-162.0%	-127.1%	-102.9%	-78.9%	-44.0%	-35.7%	-134.3%
Quartile Rank
Percentile Rank	-	19%	19%	10%	4%	6%	8%	6%	16%	24%	9%	14%

Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)